Item 2. Unregistered Sales of Equity Securities
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On May 29, 2024, we announced that our Board had authorized the repurchase of up to an additional $200.0 million aggregate purchase price (excluding any fees, commissions, or other expenses of such purchases) of Cimpress' issued and outstanding ordinary shares on the open market, through privately negotiated transactions, or in one or more self tender offers. The Board did not set an expiration date for this new repurchase program, and we may suspend or discontinue our share repurchases at any time.
The following table outlines the repurchase of our ordinary shares during the three months ended December 31, 2024 under the program described above:
Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of a Publicly Announced Program Approximate Dollar Value of Shares that May Yet be Purchased Under the Program
(in millions)
October 1, 2024 through October 31, 2024 115,866 $ 80.98 115,866 $ 173.0
November 1, 2024 through November 30, 2024 418,002 78.90 418,002 140.0
December 1, 2024 through December 31, 2024 — — — 140.0
Total 533,868 $ 79.36 533,868 $ 140.0
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.